KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Aquestive Therapeutics (AQST) Tax Provisions: 2023-2024

Historic Tax Provisions for Aquestive Therapeutics (AQST) over the last 1 years, with Dec 2024 value amounting to -$14,000.

  • Aquestive Therapeutics' Tax Provisions fell 113.86% to -$14,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $231,000, marking a year-over-year change of. This contributed to the annual value of -$14,000 for FY2024, which is 105.71% down from last year.
  • Latest data reveals that Aquestive Therapeutics reported Tax Provisions of -$14,000 as of Q4 2024, which was down 113.86% from $101,000 recorded in Q4 2023.
  • Aquestive Therapeutics' 5-year Tax Provisions high stood at $284,000 for Q2 2023, and its period low was -$140,000 during Q3 2023.
  • In the last 2 years, Aquestive Therapeutics' Tax Provisions had a median value of $43,500 in 2023 and averaged $57,750.
  • Data for Aquestive Therapeutics' Tax Provisions shows a maximum YoY crashed of 113.86% (in 2024) over the last 5 years.
  • Over the past 2 years, Aquestive Therapeutics' Tax Provisions (Quarterly) stood at $101,000 in 2023, then plummeted by 113.86% to -$14,000 in 2024.
  • Its Tax Provisions stands at -$14,000 for Q4 2024, versus $101,000 for Q4 2023 and -$140,000 for Q3 2023.